2479 East Bayshore Road
NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success as it mission. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Founder and CEO: Gini Deshpande
CSO: Craig Webb
CTO: Asim Siddiqui
CFO: Linda Ara
Please click here for NuMedii job opportunities.